Bioharvest Sciences Inc.BHST

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$1.46
Market cap
$33.1M
P/E
—
Revenue (FY)
$34.5M
Net income
-$11.1M
Dividend yield
—
1-year total return
-86.7%
Net margin
-32.3%
Revenue growth
37.0%
Debt / equity
0.01x

What Bioharvest Sciences Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year2022202320242025
Revenue—$12.7M$25.2M$34.5M
Net income—-$12.6M-$12.9M-$11.1M
Free cash flow—-$10.0M-$9.5M-$9.6M

More on BHST.

Figures from Bioharvest Sciences Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.